3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
2
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Leukemia, Myeloid, Acute
25
Breast Neoplasms
14
Neoplasms
12
Myelodysplastic Syndromes
12
Prostatic Neoplasms
10
Multiple Myeloma
8
Lung Neoplasms
7
Stomach Neoplasms
6
Sarcoma
6
Ovarian Neoplasms
5
Leukemia, Myelomonocytic, Chronic
5
Recurrence
4
Neoplasm Metastasis
4
Lymphoma, Non-Hodgkin
4
Head and Neck Neoplasms
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Advanced Solid Tumor
4
Uterine Cervical Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Solid Tumor
3
Small Cell Lung Carcinoma
3
Pain
3
Mucositis
3
Lymphoma, T-Cell, Peripheral
3
Cholangiocarcinoma
3
Carcinoma, Transitional Cell
3
Carcinoma, Hepatocellular
3
Stomatitis
2
Skin Neoplasms
2
Interventions
Paclitaxel
37
Carboplatin
28
pembrolizumab
19
Surveys and Questionnaires
11
temsirolimus
10
Radiotherapy
10
Cisplatin
10
Doxorubicin
9
Bevacizumab
9
lenvatinib
8
Docetaxel
8
Nivolumab
7
Metformin
7
Gemcitabine
7
Early Intervention, Educational
7
Counseling
7
Sirolimus
6
Radiation
6
Megestrol Acetate
6
Indocyanine Green
6
olaparib
5
Topotecan
5
Therapeutics
5
Psychiatric Rehabilitation
5
Methods
5
Letrozole
5
Ipilimumab
5
Chemotherapy, Adjuvant
5
ridaforolimus
4
Trastuzumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Endometrial Neoplasms
×
Injections
×
Clear all
NCT01673022
2018-07-24
FIRES
Indiana University
Phase NA
Completed
430 enrolled
7 charts